Trial Profile
Electronic Schizophrenia Treatment Adherence Registry.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 26 Apr 2012 Actual patient number is 408 according to ClinicalTrials.gov.
- 11 Nov 2008 New trial record.